James Campbell

Chief Executive Officer chez PATRYS LIMITED Fortune : 119 550 $ au 31/03/2024

Profil

James A.
Campbell is the founder of Prevatex Pty Ltd., VITALITY Devices Pty Ltd., and several other companies.
He currently holds multiple positions, including Chief Executive Officer, MD & Director at Patrys Ltd., Chairman at AusBiotech Ltd., Non-Executive Director at Prescient Therapeutics Ltd., Director at Fusion Biosciences Pty Ltd., and Principal at Gemini Biotechnology.
In the past, he served as Chief Executive Officer at Photonz Corp.
Ltd., Non-Executive Director at TrivarX Ltd., CBio Ltd., and Invion Ltd., Director at Hatchtech Pty Ltd.
and Pargenex Pty Ltd., Secretary, Chief Operating & Financial Officer at ChemGenex Pharmaceuticals Pty Ltd., Principal at the University of Melbourne and the Commonwealth Scientific & Industrial Research Organisation, Consultant at Booz Allen Hamilton, Inc., and Investment Committee Member at Symbiosis Group Ltd.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
PATRYS LIMITED 0,92%	04/08/2023	18 885 125 ( 0,92% )	110 856 $	31/03/2024
PRESCIENT THERAPEUTICS LIMITED 0,03%	04/04/2023	242 321 ( 0,03% )	8 694 $	31/03/2024

Postes actifs de James Campbell

Sociétés	Poste	Début
PRESCIENT THERAPEUTICS LIMITED	Director/Board Member	28/11/2014
PATRYS LIMITED	Chief Executive Officer	13/04/2015
VITALITY Devices Pty Ltd.	Founder	-
AusBiotech Ltd.	Chairman	-
Fusion Biosciences Pty Ltd.	Director/Board Member	-
Gemini Biotechnology	Corporate Officer/Principal	-

Anciens postes connus de James Campbell

Sociétés	Poste	Fin
INVION LIMITED	Director/Board Member	21/12/2019
TRIVARX LIMITED	Director/Board Member	30/09/2016
CBio Ltd.	Director/Board Member	05/09/2012
░░░░░░░░ ░░░ ░░░░	░░░░░░░	-
░░░░ ░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-